A prospective, multi-center study of Candida bloodstream infections in Chile.

María E SantolayaLuis ThompsonDona BenadofCecilia TapiaPaulette LegarragaClaudia CortésMarcela RabelloRomina ValenzuelaPamela RojasRicardo Rabagliatinull null

Published in: PloS one (2019)

Our prospective, multicenter surveillance study showed a low incidence of candidemia in Chile, with high 30-day survival, a large proportion of elderly patients, C. glabrata as the third most commonly identified strain, a 6.6% resistance to antifungal agents and a frequent use of echinocandins.

Keyphrases

candida albicans
risk factors
escherichia coli
cross sectional
pseudomonas aeruginosa